Showing 1921 - 1930 of 2252 results

Showing Results for: “type 1 diabetes”

The American Diabetes Association and Genentech Team Up to Bring Eye Health Equity Program to the DC Region

Today, the American Diabetes Association® (ADA) and Genentech, a member of the Roche Group, announced a program to increase equitable access to eye health care in the Washington, DC metropolitan area. The program, an extension of the Health Equity Now® initiative, will focus on identifying and removing barriers to care facing Black and Hispanic/Latino communities in the DC region. Diabetes-related eye disease affects nearly 8 million Americans and is the leading cause of vision loss in people 18–64 years old. Black, Native American/Alaska Native, Hispanic/Latino, and older adults living with

American Diabetes Association Applauds Maryland Passage of Law to Cap Monthly Insulin Co-Pays at $30

Yesterday, Maryland Governor Lawrence (Larry) Hogan, Jr. signed Senate Bill 353 and House Bill 1397 – a critical action that will help save lives and reduce the burden of insulin costs for people living with diabetes in Maryland. The American Diabetes Association® (ADA) applauds Governor Hogan for signing the legislation that will cap copayments for insulin at $30 per 30-day supply for those on state-regulated commercial health insurance plans. Improving insulin affordability helps people with diabetes to manage the disease, stay healthy, and reduce their risk for dangerous complications

The American Diabetes Association Applauds Illinois Governor for Approving Legislation Expanding Access to CGMs for Medicaid Beneficiaries   

The American Diabetes Association® (ADA) applauds Illinois Governor J.B. Pritzker for signing legislation (Senate Bill 3414) allowing a broader population of Illinois’ Medicaid beneficiaries to be eligible for a continuous glucose monitor (CGM), closing a significant health equity gap in access to care for people with diabetes who are insulin dependent. CGMs continually monitor blood glucose (blood sugar), giving real-time updates through a device that is attached to a person’s body. People with diabetes who use a CGM have fewer instances of hypoglycemia (low blood glucose) and can achieve a

American Diabetes Association Teams Up With Dr. Comfort To Take Next Step in Preventing and Managing Foot Complications

New interactive online experience with personalized solutions for preventing and managing diabetes-related foot complications available today! Every four minutes , an American loses a limb due to diabetes—a complication that could be preventable when given the right tools. As part of its commitment to provide access to the necessary education and resources to combat diabetes-related health complications that can lead to amputations, the American Diabetes Association ® (ADA) recently launched the Foot Care & Amputation section of Living with Diabetes . “We’re excited to partner with Dr. Comfort

Latest ADA Annual Standards of Care Includes Changes to Diabetes Screening, First-Line Therapy, Pregnancy, and Technology

Today, the American Diabetes Association ® (ADA) released its much-anticipated annual Standards of Medical Care in Diabetes (Standards of Care) . Based upon the latest scientific diabetes research and clinical trials, Standards of Care is the gold-standard for professionals in the medical field and includes vital new and updated practice guidelines to care for people with diabetes and prediabetes. "We recognize that health care providers around the world look to our Standards of Care for the latest in how new research can impact care and are excited to provide this valuable resource," said Dr

Liraglutide and Insulin More Effective in Maintaining Average Blood Glucose Levels Than Other Common Diabetes Drugs

Head-to-head comparison of glucose-lowering medications helps inform individualized treatment strategies Today, investigators sponsored by the National Institutes of Health announced findings from the largest and longest study comparing the effectiveness of common medications to treat type 2 diabetes. Results of the GRADE study were presented at the virtual 81st Scientific Sessions of the American Diabetes Association (ADA). Controlling blood glucose levels over time is a major challenge for people with type 2 diabetes, a condition that disproportionally impacts Black and Hispanic people, who

Outstanding Leaders in Specialized Areas of Diabetes Research, Prevention and Treatment to be Recognized at ADA’s 80th Scientific Sessions

The American Diabetes Association (ADA) announces this year’s Professional Interest Group and Women’s Interprofessional Network Award recipients The American Diabetes Association® (ADA) is proud to announce the recipients of the 2020 Professional Interest Group and Women’s Interprofessional Network Awards. These awards, presented by various membership groups, recognize academics, health care providers and educators who have contributed to advances in specialized areas of diabetes care and research. Each recipient has shown outstanding commitment to achieving the vision of the ADA: life free of